Congressman John Sarbanes (D-Md.) issued the following statement on May 21, 2015, after H.R. 6, the 21st Century Cures Act, passed the full Energy and Commerce Committee with bipartisan support. The bill will increase biomedical research and accelerate the approval process for new medical devices and prescription drugs, giving patients more access to life-saving treatments. […]
Category Archives: Policy
In March 2015, the Centers for Medicare and Medicaid Services (CMS) rolled out the proposed rule for Stage 3, which they declared will be the final stage of its Meaningful Use (MU) EHR incentive program. This stage is scheduled to begin in 2017.
A conversation with Jesse Pines, MD, MBA, Director of the Office of Clinical Practice Innovation at George Washington University regarding the impact of the Affordable Care Act on the current acute care system, and cost containment/utilization approaches.
Maryland SB 69/ HB 181 (“State Board of Pharmacy – Sterile Compounding – Compliance by Nonresident Pharmacies and Repeal of Permit Requirement”) sponsored by Maryland Legislative Senator Conway and Delegate Hill respectively, is MedChi (The Maryland State Medical Society) initiated legislation that would repeal the provisions of the Maryland Pharmacy Act passed in 2013 that […]
Despite his 28 years in the Maryland state legislature, Speaker Michael Busch has never taken the splendor of the House chamber for granted. The chamber is an inspirational setting for the years of legislative wrangling that have taken place within its walls.
Maryland Physician recently interviewed Donna Kinzer, executive director of the Health Services Cost Review Commission (HSCRC) since mid-2013 about the impact of the new waiver on providers and patients. More coordinated care is one of the waiver’s key goals.
Department of Health and Mental Hygiene (DHMH) Secretary Joshua Sharfstein, MD, reflects on his challenges and accomplishments and where his next position will take him.
Maryland Insurance Commissioner Therese M. Goldsmith discusses how the Affordable Care Act is impacting healthcare insurance in the state. In spite of the challenges of the new healthcare exchange in Maryland, she finds much to celebrate.
After almost 40 years under the existing Medicare waiver, and with healthcare reform underway nationally, Maryland healthcare policy leaders agreed to revise current incentives in favor of a population-based approach.
When the Maryland General Assembly passed HB 1101 in its 2013 legislative session, it made history by paving the way for the state’s first hospital-based medical marijuana program. Physicians have been an important impetus to bring this bill to fruition.